Metraipolis › archive › dc_276e1d040ffc

The association between SGLT2 inhibitors and rheumatoid arthritis risk in type 2 diabetes: findings from large-scale emulated target trials — Europe PMC PMID:42614254

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42614254
DOI
10.3389/fimmu.2026.1867117
License (as archived)
solo-consultazione
Archived
2026-10-17T04:27:21.467Z
SHA-256 of the archived text
4ce7119a4c9ceec9b1de2dbe97eca29ffbfe135df9e9f46c5b58a6f955f2d552
Stable URL of this page
https://metraipolis.com/documento/dc_276e1d040ffc

How to cite

The association between SGLT2 inhibitors and rheumatoid arthritis risk in type 2 diabetes: findings from large-scale emulated target trials — Europe PMC PMID:42614254 — Europe PMC (en), https://europepmc.org/article/MED/42614254 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_276e1d040ffc (Metraipolis archive dc_276e1d040ffc, sha256 4ce7119a4c9ceec9b1de2dbe97eca29ffbfe135df9e9f46c5b58a6f955f2d552)
BibTeX
@misc{dc276e1d040ffc,
  title = {The association between SGLT2 inhibitors and rheumatoid arthritis risk in type 2 diabetes: findings from large-scale emulated target trials — Europe PMC PMID:42614254},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42614254},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_276e1d040ffc; sha256 4ce7119a4c9ceec9b1de2dbe97eca29ffbfe135df9e9f46c5b58a6f955f2d552},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42614254. Agents can read the archived copy with the MCP tool read_document.